Jin Medical International (ZJYL) Cash & Current Investments (2022 - 2026)

Jin Medical International has reported Cash & Current Investments for 4 years, with the latest figure at $29.6 million in Q3 2025.

• Quarterly Cash & Current Investments rose 59.12% year-over-year to $29.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $29.6 million (down 40.98% YoY) and the FY2025 annual result came in at $29.6 million, up 59.12% from the prior year.
• Cash & Current Investments improved to $29.6 million in Q3 2025 per ZJYL's latest filing, from $19.8 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $29.6 million in Q3 2025 and troughed at $2.3 million in Q3 2022.
• A 4-year average of $14.6 million and a median of $17.1 million in 2024 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2023 and 2025: Cash & Current Investments soared 329.18% in 2023, then advanced 15.85% in 2025.
• Over 4 years, Cash & Current Investments stood at $2.3 million in 2022, then jumped by 329.18% to $9.8 million in 2023, then soared by 90.62% to $18.6 million in 2024, then surged by 59.12% to $29.6 million in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $29.6 million, $19.8 million, and $18.6 million for Q3 2025, Q1 2025, and Q3 2024 respectively.